Andrew L. Finn,Pharm.D
Overview
Andrew L. Finn,Pharm.D received an average of $1M in total compensation, including $306K in salary, at BioDelivery Sciences International from 2012 to 2014.
Source: SEC filing on June 5, 2015.
Related executives
We found 11 more executives who work or worked at BioDelivery Sciences International.
Mark Sirgo
BioDelivery Sciences International
Chief Executive Officer
Niraj Vasisht
BioDelivery Sciences International
Chief Technology Officer
Ernest De Paolantonio
BioDelivery Sciences International
Chief Financial Officer
Andrew Finn
BioDelivery Sciences International
Executive VP of Product Development
Mark SirgoPharmD
BioDelivery Sciences International
Chief Executive Officer
Ernest De PaolantonioCPA
BioDelivery Sciences International
Chief Financial Officer
James McNulty
BioDelivery Sciences International
Chief Financial Officer
Benny Ward
BioDelivery Sciences International